发明授权
US6057319A 3,4-Diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors
失效
3,4-二芳基-2-羟基-2,5-二氢呋喃作为前药,用于cox-2抑制剂
- 专利标题: 3,4-Diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors
- 专利标题(中): 3,4-二芳基-2-羟基-2,5-二氢呋喃作为前药,用于cox-2抑制剂
-
申请号: US68139申请日: 1998-10-02
-
公开(公告)号: US6057319A公开(公告)日: 2000-05-02
- 发明人: Cameron Black , Serge Leger , Petpiboon Prasit , Zhaoyin Wang , Pierre Hamel , Yongxin Han , Gregory Hughes
- 申请人: Cameron Black , Serge Leger , Petpiboon Prasit , Zhaoyin Wang , Pierre Hamel , Yongxin Han , Gregory Hughes
- 申请人地址: CAX Kirkland
- 专利权人: Merck Frosst Canada & Co.
- 当前专利权人: Merck Frosst Canada & Co.
- 当前专利权人地址: CAX Kirkland
- 主分类号: C07C323/64
- IPC分类号: C07C323/64 ; C07D213/34 ; C07D307/30 ; C07D307/32 ; C07D307/58 ; C07D307/60 ; C07D307/62 ; C07D307/64 ; C07D307/66 ; C07D307/68 ; C07D307/94 ; C07D405/04 ; C07D405/12 ; C07D409/12 ; C07D417/12 ; A61K31/53 ; A61K31/415 ; C07D213/06 ; C07D253/08 ; C07D261/04
摘要:
The invention encompasses the novel compound of formula (I) useful in the treatment of cyclooxygenase-2 mediated diseases. The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of formula (I). ##STR1##
公开/授权文献
- USD391141S Door latch 公开/授权日:1998-02-24